{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:04:24Z","timestamp":1785852264999,"version":"3.56.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>\n                    Papillary thyroid carcinoma, columnar cell subtype (PTC-CC) is a PTC characterized by nuclear pseudostratification and elongation. High-grade differentiated thyroid carcinoma is a novel classification of the WHO classification, defined by mitotic count \u22655\/2\u00a0mm\n                    <jats:sup>2<\/jats:sup>\n                    and\/or tumor necrosis, which may exhibit CC morphology and can be termed as high-grade PTC-CC (HGPTC-CC). In this multicenter retrospective study, we conducted a detailed clinicopathologic review in a retrospective cohort of 71 PTC-CC and HGPTC-CC. HGPTC-CC was common among tumors showing columnar cell morphology, accounting for 46% (33\/71) of the entire cohort. Compared with PTC-CC, HGPTC-CC was significantly associated with male sex, infiltrative tumors, angioinvasion, microscopic extrathyroidal extension (ETE), positive resection margin, and advanced pT stage. Furthermore, HGPTC-CC had significantly shortened disease-specific survival (DSS), distant metastasis-free survival (DMFS), and regional recurrence-free survival (RRFS). The 10-year DSS was 95% and 57%, the 10-year DMFS was 87% and 26%, and the 10-year RRFS was 85% and 55% for PTC-CC and HGPTC-CC, respectively. Among tumors with known\n                    <jats:italic toggle=\"yes\">BRAF<\/jats:italic>\n                    <jats:sup>V600E<\/jats:sup>\n                    and\n                    <jats:italic toggle=\"yes\">RAS<\/jats:italic>\n                    <jats:sup>Q61R<\/jats:sup>\n                    status,\n                    <jats:italic toggle=\"yes\">BRAF<\/jats:italic>\n                    <jats:sup>V600E<\/jats:sup>\n                    mutation was detected in 40% (19\/47), whereas\n                    <jats:italic toggle=\"yes\">RAS<\/jats:italic>\n                    <jats:sup>Q61R<\/jats:sup>\n                    was identified in 15% (6\/39). HGPTC-CC was associated with a significantly higher percentage of\n                    <jats:italic toggle=\"yes\">RAS<\/jats:italic>\n                    <jats:sup>Q61R<\/jats:sup>\n                    (PTC-CC 4%, HGPTC-CC 36%). In conclusion, a significant percentage (46%) of PTC-CCs are high-grade. HGPTC-CC is associated with adverse clinicopathologic features and poor outcomes. The impression of PTC-CC as an aggressive PTC subtype may be attributed to the high prevalence of high-grade histology in these tumors. Careful examination for mitoses and necrosis is required for accurate diagnosis and prognostication in PTC-CC.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002551","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:00:29Z","timestamp":1776142829000},"page":"865-871","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Columnar Cell Subtype of Papillary Thyroid Carcinoma Is Characterized By A High Frequency of High-Grade Tumors That Exhibit Aggressive Clinicopathologic Features and Poor Outcomes"],"prefix":"10.1097","volume":"50","author":[{"given":"Kartik","family":"Viswanathan","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayan","family":"Alzumaili","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Lazim","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moaz K.","family":"Mneinneh","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sadow","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Ghossein","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"Cipriani","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4638-9835","authenticated-orcid":false,"given":"Bin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"R2-20260715","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association Management Guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"key":"R3-20260715","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/his.14550","article-title":"Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases","volume":"80","author":"Xu","year":"2022","journal-title":"Histopathology"},{"key":"R4-20260715","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/ajcp\/85.1.77","article-title":"Columnar-cell carcinoma of the thyroid. A report of two cases of an aggressive variant of thyroid carcinoma","volume":"85","author":"Evans","year":"1986","journal-title":"Am J Clin Pathol"},{"key":"R5-20260715","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<740::AID-CNCR18>3.0.CO;2-Y","article-title":"Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases","volume":"82","author":"Wenig","year":"1998","journal-title":"Cancer"},{"key":"R6-20260715","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/modpathol.2011.2","article-title":"Clinicopathological and molecular characterization of nine cases of columnar cell variant of papillary thyroid carcinoma","volume":"24","author":"Chen","year":"2011","journal-title":"Mod Pathol"},{"key":"R7-20260715","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1309\/AJCPXE3PUBWVZCGZ","article-title":"CDX2 expression in columnar cell variant of papillary thyroid carcinoma","volume":"137","author":"Enriquez","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"R8-20260715","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1089\/thy.2012.0455","article-title":"Columnar cell variant of papillary thyroid carcinoma: a study of 10 cases with emphasis on CDX2 expression","volume":"23","author":"Sujoy","year":"2013","journal-title":"Thyroid"},{"key":"R9-20260715","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/his.14374","article-title":"Genomic profile of columnar cell variant of papillary thyroid carcinoma","volume":"79","author":"Janovitz","year":"2021","journal-title":"Histopathology"},{"key":"R10-20260715","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12105-024-01645-2","article-title":"Columnar cell thyroid carcinoma: a heterogeneous entity demonstrating overlap between papillary thyroid carcinoma and follicular neoplasms","volume":"18","author":"Higgins","year":"2024","journal-title":"Head Neck Pathol"},{"key":"R11-20260715","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00000478-199610000-00005","article-title":"Encapsulated columnar-cell neoplasms of the thyroid. A report of four cases suggesting a favorable prognosis","volume":"20","author":"Evans","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R12-20260715","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/his.70032","article-title":"The prognostic impact of blood vessel invasion in infiltrative papillary thyroid carcinoma: a retrospective case-control study","volume":"88","author":"Ghossein","year":"2026","journal-title":"Histopathology"},{"key":"R13-20260715","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"R14-20260715","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/his.15157","article-title":"Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a retrospective study of 1456 patients","volume":"84","author":"Ghossein","year":"2024","journal-title":"Histopathology"},{"key":"R15-20260715","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1007\/s00405-025-09394-w","article-title":"Analysis of risk factors for distant metastasis of column cell subtypes of thyroid papillary carcinoma","volume":"282","author":"Su","year":"2025","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R16-20260715","first-page":"e66913","article-title":"Demographic and prognostic factors of the columnar cell variant of papillary thyroid carcinoma: a national cancer database study","volume":"16","author":"Puvvadi","year":"2024","journal-title":"Cureus"},{"key":"R17-20260715","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12022-021-09683-0","article-title":"Cribriform-morular thyroid carcinoma is a distinct thyroid malignancy of uncertain cytogenesis","volume":"32","author":"Boyraz","year":"2021","journal-title":"Endocr Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002551","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:39:32Z","timestamp":1785850772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002551"}},"subtitle":["A Multicenter Study of 71 Cases"],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002551","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]}}}